Ocular surface involvements in ectrodactyly-ectodermal dysplasia-cleft syndrome

David P. Kennedy, John W. Chandler, James P McCulley

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose: To present the ocular manifestation of 2 cases of ectrodactyly-ectodermal dysplasia-cleft syndrome, a multiple congenital anomaly syndrome caused by a single point mutation of the p63 gene that controls epidermal development and homeostasis and to present treatment options. Case reports and discussion: Patient 1 presented with mild signs and symptoms of dry eye and limbal stem cell deficiency with retention of 20/30 vision. Patient 2 presented with severe signs and symptoms of limbal stem cell deficiency with diffuse corneal scarring and counting fingers vision. This second patient's course was complicated by allergic conjunctivitis and advanced steroid-induced glaucoma. The cause of visual loss in ectrodactyly-ectodermal dysplasia-cleft syndrome appears to be multifactorial and likely includes inflammation of the ocular surface, tear film abnormalities, eyelid abnormalities, and limbal stem cell deficiency. Treatment modalities including lubrication, contact lenses, and limbal stem cell transplantation are reviewed. Conclusions: The ophthalmic conditions seen in ectrodactyly-ectodermal dysplasia-cleft syndrome frequently lead to vision loss. Early correct diagnosis and appropriate therapy are paramount because p63 gene mutations have a critical role in maintaining the integrity of the ocular surface in the setting of limbal stem cell deficiency, especially if there are other ocular surface insults such as lid disease, meibomian gland dysfunction and toxicity from topical medications. Patients should be monitored at regular, frequent intervals; and particular attention should be taken to avoid adverse secondary effects of these conditions and medications.

Original languageEnglish (US)
Pages (from-to)228-231
Number of pages4
JournalContact Lens and Anterior Eye
Volume38
Issue number3
DOIs
StatePublished - Jun 1 2015

Fingerprint

Ectodermal Dysplasia
Stem Cells
Signs and Symptoms
Eye Manifestations
Meibomian Glands
Allergic Conjunctivitis
Lubrication
Contact Lenses
Stem Cell Transplantation
Eyelids
Tears
Point Mutation
Glaucoma
Genes
Fingers
Cicatrix
Early Diagnosis
Homeostasis
Therapeutics
Steroids

Keywords

  • Corneal epithelial stem cells
  • Corneal stromal stem cells
  • Ectrodactyly-ectodermal dysplasia-cleft syndrome
  • Ocular surface disorders
  • P63 mutations

ASJC Scopus subject areas

  • Ophthalmology
  • Optometry

Cite this

Ocular surface involvements in ectrodactyly-ectodermal dysplasia-cleft syndrome. / Kennedy, David P.; Chandler, John W.; McCulley, James P.

In: Contact Lens and Anterior Eye, Vol. 38, No. 3, 01.06.2015, p. 228-231.

Research output: Contribution to journalArticle

@article{d2da335068a54e669486785673f30c6a,
title = "Ocular surface involvements in ectrodactyly-ectodermal dysplasia-cleft syndrome",
abstract = "Purpose: To present the ocular manifestation of 2 cases of ectrodactyly-ectodermal dysplasia-cleft syndrome, a multiple congenital anomaly syndrome caused by a single point mutation of the p63 gene that controls epidermal development and homeostasis and to present treatment options. Case reports and discussion: Patient 1 presented with mild signs and symptoms of dry eye and limbal stem cell deficiency with retention of 20/30 vision. Patient 2 presented with severe signs and symptoms of limbal stem cell deficiency with diffuse corneal scarring and counting fingers vision. This second patient's course was complicated by allergic conjunctivitis and advanced steroid-induced glaucoma. The cause of visual loss in ectrodactyly-ectodermal dysplasia-cleft syndrome appears to be multifactorial and likely includes inflammation of the ocular surface, tear film abnormalities, eyelid abnormalities, and limbal stem cell deficiency. Treatment modalities including lubrication, contact lenses, and limbal stem cell transplantation are reviewed. Conclusions: The ophthalmic conditions seen in ectrodactyly-ectodermal dysplasia-cleft syndrome frequently lead to vision loss. Early correct diagnosis and appropriate therapy are paramount because p63 gene mutations have a critical role in maintaining the integrity of the ocular surface in the setting of limbal stem cell deficiency, especially if there are other ocular surface insults such as lid disease, meibomian gland dysfunction and toxicity from topical medications. Patients should be monitored at regular, frequent intervals; and particular attention should be taken to avoid adverse secondary effects of these conditions and medications.",
keywords = "Corneal epithelial stem cells, Corneal stromal stem cells, Ectrodactyly-ectodermal dysplasia-cleft syndrome, Ocular surface disorders, P63 mutations",
author = "Kennedy, {David P.} and Chandler, {John W.} and McCulley, {James P}",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.clae.2015.02.002",
language = "English (US)",
volume = "38",
pages = "228--231",
journal = "Contact Lens and Anterior Eye",
issn = "1367-0484",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Ocular surface involvements in ectrodactyly-ectodermal dysplasia-cleft syndrome

AU - Kennedy, David P.

AU - Chandler, John W.

AU - McCulley, James P

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Purpose: To present the ocular manifestation of 2 cases of ectrodactyly-ectodermal dysplasia-cleft syndrome, a multiple congenital anomaly syndrome caused by a single point mutation of the p63 gene that controls epidermal development and homeostasis and to present treatment options. Case reports and discussion: Patient 1 presented with mild signs and symptoms of dry eye and limbal stem cell deficiency with retention of 20/30 vision. Patient 2 presented with severe signs and symptoms of limbal stem cell deficiency with diffuse corneal scarring and counting fingers vision. This second patient's course was complicated by allergic conjunctivitis and advanced steroid-induced glaucoma. The cause of visual loss in ectrodactyly-ectodermal dysplasia-cleft syndrome appears to be multifactorial and likely includes inflammation of the ocular surface, tear film abnormalities, eyelid abnormalities, and limbal stem cell deficiency. Treatment modalities including lubrication, contact lenses, and limbal stem cell transplantation are reviewed. Conclusions: The ophthalmic conditions seen in ectrodactyly-ectodermal dysplasia-cleft syndrome frequently lead to vision loss. Early correct diagnosis and appropriate therapy are paramount because p63 gene mutations have a critical role in maintaining the integrity of the ocular surface in the setting of limbal stem cell deficiency, especially if there are other ocular surface insults such as lid disease, meibomian gland dysfunction and toxicity from topical medications. Patients should be monitored at regular, frequent intervals; and particular attention should be taken to avoid adverse secondary effects of these conditions and medications.

AB - Purpose: To present the ocular manifestation of 2 cases of ectrodactyly-ectodermal dysplasia-cleft syndrome, a multiple congenital anomaly syndrome caused by a single point mutation of the p63 gene that controls epidermal development and homeostasis and to present treatment options. Case reports and discussion: Patient 1 presented with mild signs and symptoms of dry eye and limbal stem cell deficiency with retention of 20/30 vision. Patient 2 presented with severe signs and symptoms of limbal stem cell deficiency with diffuse corneal scarring and counting fingers vision. This second patient's course was complicated by allergic conjunctivitis and advanced steroid-induced glaucoma. The cause of visual loss in ectrodactyly-ectodermal dysplasia-cleft syndrome appears to be multifactorial and likely includes inflammation of the ocular surface, tear film abnormalities, eyelid abnormalities, and limbal stem cell deficiency. Treatment modalities including lubrication, contact lenses, and limbal stem cell transplantation are reviewed. Conclusions: The ophthalmic conditions seen in ectrodactyly-ectodermal dysplasia-cleft syndrome frequently lead to vision loss. Early correct diagnosis and appropriate therapy are paramount because p63 gene mutations have a critical role in maintaining the integrity of the ocular surface in the setting of limbal stem cell deficiency, especially if there are other ocular surface insults such as lid disease, meibomian gland dysfunction and toxicity from topical medications. Patients should be monitored at regular, frequent intervals; and particular attention should be taken to avoid adverse secondary effects of these conditions and medications.

KW - Corneal epithelial stem cells

KW - Corneal stromal stem cells

KW - Ectrodactyly-ectodermal dysplasia-cleft syndrome

KW - Ocular surface disorders

KW - P63 mutations

UR - http://www.scopus.com/inward/record.url?scp=84929708405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929708405&partnerID=8YFLogxK

U2 - 10.1016/j.clae.2015.02.002

DO - 10.1016/j.clae.2015.02.002

M3 - Article

C2 - 25769661

AN - SCOPUS:84929708405

VL - 38

SP - 228

EP - 231

JO - Contact Lens and Anterior Eye

JF - Contact Lens and Anterior Eye

SN - 1367-0484

IS - 3

ER -